Coherus BioSciences to Report Third Quarter 2022 Financial Results on November 8th, 2022
Coherus BioSciences (CHRS) has announced its third quarter 2022 financial results will be released on November 8, 2022, after market close. Following the release, management will host a conference call at 5:00 p.m. Eastern Time to discuss the results and provide a business update. Investors can access the press release and related materials on the official website before the call. A replay of the webcast will be available post-call. Pre-registration is required for call access, ensuring a timely connection.
- None.
- None.
REDWOOD CITY, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its third quarter 2022 financial results will be released after market close on Tuesday, November 8th, 2022. Starting at 5:00 p.m. Eastern Time on November 8, 2022, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update. The press release with the third quarter 2022 financial results and related materials will be available at https://investors.coherus.com prior to the start of the conference call.
A replay of the webcast will be available on http://investors.coherus.com following the conclusion of the live conference call.
Conference Call Information
When: Tuesday, November 8th, 2022, starting at 5:00 p.m. Eastern Time
To access the conference call, please pre-register through the following link to receive dial-in information and personal PIN to access the live call: https://register.vevent.com/register/BI79684ca1b45c46df988c8f9aac6f09af
Webcast: https://investors.coherus.com/upcoming-events
Please dial-in 15 minutes early to ensure a timely connection to the call.
Coherus Contact Information:
Marek Ciszewski, SVP Investor Relations
Coherus Biosciences, Inc.
IR@coherus.com
FAQ
When will Coherus BioSciences announce its third quarter 2022 results?
What time is the Coherus BioSciences conference call scheduled?
Where can I find the press release for Coherus BioSciences' Q3 2022 results?
How can I access the Coherus BioSciences conference call?